Status not kept up to date
Telerehabilitation Protocols With Digital and Robotic Tools for People With Chronic Neurological Disorders
NCT06009770 · Fondazione Don Carlo Gnocchi ETS · Updated 24 Aug 2023
- What is being tested
- medical device "Homing" (TecnoBody); medical device "Icone" (Heaxel); Usual Care
- For
- Post-stroke; Parkinson Disease; Multiple Sclerosis
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 25 years to 85 years. About 90 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 1 Sept 2023, ends 1 Jan 2025. Registered 24 Aug 2023.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical trial is to test an innovative telerehabilitation protocol in people with Chronic Neurological Disorders (Parkinson's disease, Multiple Sclerosis, and post-stroke). The main questions it aims to answer are 1)the usability and acceptability of the system; 2)the level of safety of intervention; 3) the efficacy of the telerehabilitation protocol. Participants will be randomized (with an allocation ratio of 1:1) into either the experimental group (20 sessions of motor telerehabilitation with digital and robotic tools) or the active control group (20 motor rehabilitation sessions performed at home according to the usual care treatment procedure). Researchers will compare the experimental group and the active control group to see if the TR protocol with digital and robotic tools is effective in reducing the perceived level of disability.